189 related articles for article (PubMed ID: 34541026)
1. Studies of hormonal regulation, phenotype plasticity, bone metastasis, and experimental therapeutics in androgen-repressed human prostate cancer (ARCaP) model.
Lo UG; Chen YA; Khamis ZI; Kao WH; Hsieh JT; Sang QA
Am J Clin Exp Urol; 2021; 9(4):277-286. PubMed ID: 34541026
[TBL] [Abstract][Full Text] [Related]
2. Epithelial to mesenchymal transition (EMT) in human prostate cancer: lessons learned from ARCaP model.
Zhau HE; Odero-Marah V; Lue HW; Nomura T; Wang R; Chu G; Liu ZR; Zhou BP; Huang WC; Chung LW
Clin Exp Metastasis; 2008; 25(6):601-10. PubMed ID: 18535913
[TBL] [Abstract][Full Text] [Related]
3. Receptor activator of NF-kappaB Ligand (RANKL) expression is associated with epithelial to mesenchymal transition in human prostate cancer cells.
Odero-Marah VA; Wang R; Chu G; Zayzafoon M; Xu J; Shi C; Marshall FF; Zhau HE; Chung LW
Cell Res; 2008 Aug; 18(8):858-70. PubMed ID: 18645583
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of minichromosome maintenance complex component 3 during epithelial-to-mesenchymal transition in human prostate cancer.
Stewart PA; Khamis ZI; Zhau HE; Duan P; Li Q; Chung LWK; Sang QA
Oncotarget; 2017 Jun; 8(24):39209-39217. PubMed ID: 28424404
[TBL] [Abstract][Full Text] [Related]
5. Epithelial protein lost in neoplasm (EPLIN) and prostate cancer: lessons learned from the ARCaP model.
Wu D; Osunkoya AO; Kucuk O
Am J Clin Exp Urol; 2021; 9(4):264-276. PubMed ID: 34541025
[TBL] [Abstract][Full Text] [Related]
6. Secretome analysis reveals upregulated granzyme B in human androgen-repressed prostate cancer cells with mesenchymal and invasive phenotype.
Bou-Dargham MJ; Sang QA
PLoS One; 2020; 15(8):e0237222. PubMed ID: 32764784
[TBL] [Abstract][Full Text] [Related]
7. Androgen-repressed phenotype in human prostate cancer.
Zhau HY; Chang SM; Chen BQ; Wang Y; Zhang H; Kao C; Sang QA; Pathak SJ; Chung LW
Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15152-7. PubMed ID: 8986779
[TBL] [Abstract][Full Text] [Related]
8. Prostate cancer metastasis: role of the host microenvironment in promoting epithelial to mesenchymal transition and increased bone and adrenal gland metastasis.
Xu J; Wang R; Xie ZH; Odero-Marah V; Pathak S; Multani A; Chung LW; Zhau HE
Prostate; 2006 Nov; 66(15):1664-73. PubMed ID: 16902972
[TBL] [Abstract][Full Text] [Related]
9. Tumor-Stromal Interactions Influence Radiation Sensitivity in Epithelial- versus Mesenchymal-Like Prostate Cancer Cells.
Josson S; Sharp S; Sung SY; Johnstone PA; Aneja R; Wang R; Gururajan M; Turner T; Chung LW; Yates C
J Oncol; 2010; 2010():. PubMed ID: 20798867
[TBL] [Abstract][Full Text] [Related]
10. Androgens induce a distinct response of epithelial-mesenchymal transition factors in human prostate cancer cells.
Colditz J; Rupf B; Maiwald C; Baniahmad A
Mol Cell Biochem; 2016 Oct; 421(1-2):139-47. PubMed ID: 27562825
[TBL] [Abstract][Full Text] [Related]
11. Silibinin reverses epithelial-to-mesenchymal transition in metastatic prostate cancer cells by targeting transcription factors.
Wu K; Zeng J; Li L; Fan J; Zhang D; Xue Y; Zhu G; Yang L; Wang X; He D
Oncol Rep; 2010 Jun; 23(6):1545-52. PubMed ID: 20428808
[TBL] [Abstract][Full Text] [Related]
12. Role of GLI-1 in epidermal growth factor-induced invasiveness of ARCaPE prostate cancer cells.
Zhu G; Zhou J; Song W; Wu D; Dang Q; Zhang L; Li L; Wang X; He D
Oncol Rep; 2013 Aug; 30(2):904-10. PubMed ID: 23757299
[TBL] [Abstract][Full Text] [Related]
13. Neuroendocrine Differentiation of Prostate Cancer-An Intriguing Example of Tumor Evolution at Play.
Patel GK; Chugh N; Tripathi M
Cancers (Basel); 2019 Sep; 11(10):. PubMed ID: 31547070
[TBL] [Abstract][Full Text] [Related]
14. AKR1C3, a crucial androgenic enzyme in prostate cancer, promotes epithelial-mesenchymal transition and metastasis through activating ERK signaling.
Wang B; Gu Y; Hui K; Huang J; Xu S; Wu S; Li L; Fan J; Wang X; Hsieh JT; He D; Wu K
Urol Oncol; 2018 Oct; 36(10):472.e11-472.e20. PubMed ID: 30139661
[TBL] [Abstract][Full Text] [Related]
15. Prostate tumor neuroendocrine differentiation via EMT: The road less traveled.
Dicken H; Hensley PJ; Kyprianou N
Asian J Urol; 2019 Jan; 6(1):82-90. PubMed ID: 30775251
[TBL] [Abstract][Full Text] [Related]
16. PRKAR2B promotes prostate cancer metastasis by activating Wnt/β-catenin and inducing epithelial-mesenchymal transition.
Sha J; Han Q; Chi C; Zhu Y; Pan J; Dong B; Huang Y; Xia W; Xue W
J Cell Biochem; 2018 Sep; 119(9):7319-7327. PubMed ID: 29761841
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of the alpha2 chain of the interleukin-13 receptor in metastatic human prostate cancer ARCaPM cells.
He H; Xu J; Nelson PS; Marshall FF; Chung LW; Zhau HE; He D; Wang R
Prostate; 2010 Jun; 70(9):993-1001. PubMed ID: 20166133
[TBL] [Abstract][Full Text] [Related]
18. Progressive epithelial to mesenchymal transitions in ARCaP E prostate cancer cells during xenograft tumor formation and metastasis.
He H; Yang X; Davidson AJ; Wu D; Marshall FF; Chung LW; Zhau HE; Wang R
Prostate; 2010 Apr; 70(5):518-28. PubMed ID: 19918799
[TBL] [Abstract][Full Text] [Related]
19. Focus on the tumor microenvironment: A seedbed for neuroendocrine prostate
Zhou H; He Q; Li C; Alsharafi BLM; Deng L; Long Z; Gan Y
Front Cell Dev Biol; 2022; 10():955669. PubMed ID: 35938167
[TBL] [Abstract][Full Text] [Related]
20. SRC family kinase FYN promotes the neuroendocrine phenotype and visceral metastasis in advanced prostate cancer.
Gururajan M; Cavassani KA; Sievert M; Duan P; Lichterman J; Huang JM; Smith B; You S; Nandana S; Chu GC; Mink S; Josson S; Liu C; Morello M; Jones LW; Kim J; Freeman MR; Bhowmick N; Zhau HE; Chung LW; Posadas EM
Oncotarget; 2015 Dec; 6(42):44072-83. PubMed ID: 26624980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
